SCHEMBL12009037

SCHEMBL12009037

Cc1ccc(C)c(-n2c(C)cc(C=C3SC(=O)N(c4ccccc4)C3=O)c2C)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TCF4 P15884 1/20 0.66
▸ CTNNB1 P35222 1/20 0.66
▸ HDAC6 Q9UBN7 1/20 0.66
▸ MYC P01106 1/20 0.53
▸ POLB P06746 3/20 0.50
▸ NPC1 O15118 11/20 0.49
▸ RAB9A P51151 11/20 0.49
▸ KMT2A Q03164 9/20 0.49
▸ ALDH1A1 P00352 8/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ MEN1 O00255 8/20 0.48
▸ MAPT P10636 7/20 0.48
▸ S1PR4 O95977 3/20 0.48
▸ S1PR1 P21453 2/20 0.48
▸ S1PR5 Q9H228 2/20 0.48
▸ NPSR1 Q6W5P4 3/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ TNNI3 P19429 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18545578 1.00 TCF4 (0.66) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL18545440 0.93 TCF4 (0.65) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL12009063 0.93 TCF4 (0.65) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL18545614 0.91 TCF4 (0.69) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL12009116 0.91 TCF4 (0.69) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL13464669 0.91 TCF4 (0.63) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL18545664 0.89 TCF4 (0.64) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL12009074 0.89 TCF4 (0.64) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL12009727 0.89 TCF4 (0.61) TCF4CTNNB1HDAC6MYCPOLB
SCHEMBL18545612 0.88 TCF4 (0.73) TCF4CTNNB1HDAC6POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 TCF4 22/4885CTNNB1 1/4885HDAC6 217/4885
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 TCF4 24/4885CTNNB1 1/4885HDAC6 74/4885
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 TCF4 24/4885CTNNB1 1/4885HDAC6 74/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 TCF4 24/4885CTNNB1 1/4885HDAC6 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback